These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Drug therapy of diabetic neuropathy. Brooks PJ; Francisco GE Clin Podiatr Med Surg; 1992 Apr; 9(2):257-74. PubMed ID: 1586903 [TBL] [Abstract][Full Text] [Related]
33. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites. El-Kabbani O; Wilson DK; Petrash M; Quiocho FA Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955 [TBL] [Abstract][Full Text] [Related]
34. The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy. Florkowski CM Med J Aust; 1993 Nov; 159(10):711-2. PubMed ID: 8110237 [No Abstract] [Full Text] [Related]
35. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)]. Christensen JE; Larsen AB; Gregersen G Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975 [No Abstract] [Full Text] [Related]
36. New approaches for treatment in diabetes: aldose reductase inhibitors. Hotta N Biomed Pharmacother; 1995; 49(5):232-43. PubMed ID: 7579002 [No Abstract] [Full Text] [Related]
38. The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy. Wright M; Hill S; Slaney MA Med J Aust; 1994 Jan; 160(1):45. PubMed ID: 8123141 [No Abstract] [Full Text] [Related]